These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12508152)

  • 1. Human T lymphocyte response to Borrelia burgdorferi infection: no correlation between human leukocyte function antigen type 1 peptide response and clinical status.
    Kalish RS; Wood JA; Golde W; Bernard R; Davis LE; Grimson RC; Coyle PK; Luft BJ
    J Infect Dis; 2003 Jan; 187(1):102-8. PubMed ID: 12508152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi.
    Chen J; Field JA; Glickstein L; Molloy PJ; Huber BT; Steere AC
    Arthritis Rheum; 1999 Sep; 42(9):1813-22. PubMed ID: 10513794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato.
    Drouin EE; Glickstein LJ; Steere AC
    J Autoimmun; 2004 Nov; 23(3):281-92. PubMed ID: 15501399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
    Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells.
    Trollmo C; Meyer AL; Steere AC; Hafler DA; Huber BT
    J Immunol; 2001 Apr; 166(8):5286-91. PubMed ID: 11290815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
    Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL
    J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease.
    Vaz A; Glickstein L; Field JA; McHugh G; Sikand VK; Damle N; Steere AC
    Infect Immun; 2001 Dec; 69(12):7437-44. PubMed ID: 11705918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis.
    Steere AC; Gross D; Meyer AL; Huber BT
    J Autoimmun; 2001 May; 16(3):263-8. PubMed ID: 11334491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mimicry to Borrelia burgdorferi: pathway to autoimmunity?
    Bolz DD; Weis JJ
    Autoimmunity; 2004 Aug; 37(5):387-92. PubMed ID: 15621562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell epitope mapping of the Borrelia garinii outer surface protein A in lyme neuroborreliosis.
    Widhe M; Ekerfelt C; Jarefors S; Skogman BH; Peterson EM; Bergström S; Forsberg P; Ernerudh J
    Scand J Immunol; 2009 Aug; 70(2):141-8. PubMed ID: 19630920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunopathology of Lyme arthritis].
    Pancewicz SA; Rutkowski R; Rutkowski K; Zajkowska JM; Kondrusik M
    Pol Merkur Lekarski; 2007 Aug; 23(134):141-4. PubMed ID: 18044347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease.
    Schutzer SE; Coyle PK; Krupp LB; Deng Z; Belman AL; Dattwyler R; Luft BJ
    J Clin Invest; 1997 Aug; 100(4):763-7. PubMed ID: 9259573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
    Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
    J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.
    Ledue TB; Collins MF; Young J; Schriefer ME
    Clin Vaccine Immunol; 2008 Dec; 15(12):1796-804. PubMed ID: 18945880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.
    Gross DM; Forsthuber T; Tary-Lehmann M; Etling C; Ito K; Nagy ZA; Field JA; Steere AC; Huber BT
    Science; 1998 Jul; 281(5377):703-6. PubMed ID: 9685265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on OspA: a source of new paradigms in Lyme disease research.
    Philipp MT
    Trends Microbiol; 1998 Feb; 6(2):44-7. PubMed ID: 9507636
    [No Abstract]   [Full Text] [Related]  

  • 17. Borrelia burgdorferi outer surface protein (osp) B expression independent of ospA.
    Liang FT; Caimano MJ; Radolf JD; Fikrig E
    Microb Pathog; 2004 Jul; 37(1):35-40. PubMed ID: 15194158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis.
    Steere AC; Falk B; Drouin EE; Baxter-Lowe LA; Hammer J; Nepom GT
    Arthritis Rheum; 2003 Feb; 48(2):534-40. PubMed ID: 12571864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula.
    Nassal M; Skamel C; Kratz PA; Wallich R; Stehle T; Simon MM
    Eur J Immunol; 2005 Feb; 35(2):655-65. PubMed ID: 15668917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arthritis following recombinant outer surface protein A vaccination for Lyme disease.
    Rosé CD; Fawcett PT; Gibney KM
    J Rheumatol; 2001 Nov; 28(11):2555-7. PubMed ID: 11708435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.